Singular Genomics
Singular Genomics Books $400K in Q3 Revenues as Net Loss Narrows
During the quarter, the company shipped its first G4X early-access instrument as well as two commercial G4 sequencing systems.
Singular Genomics Shares Soar After Deerfield Management More Than Doubles Takeover Offer
The amended proposal offers to acquire all outstanding shares of Singular's common stock it does not already own for $24 per share.
Singular Genomics Systems Gets Buyout Offer From Tang Capital Partners
The offer comes less than a week after the San Diego-based sequencing technology firm received a takeover proposal from Deerfield Management.
Singular Genomics Shares Soar on Deerfield Management Takeover Proposal
Funds and individuals associated with Deerfield control nearly 1 million shares of Singular, or approximately 27 percent of the firm, according to an SEC filing.
Singular Genomics Records $700K in Q2 Revenues
Revenue for the quarter consisted of $400,000 from consumables sales and $300,000 from an instrument placement.
May 14, 2024
Singular Genomics Q1 Revenues Fall 49 Percent
Apr 9, 2024
Nov 15, 2023
Aug 18, 2023
Mar 2, 2023
Singular Genomics Reports First Revenues in Q4
Jan 5, 2023
Aug 10, 2022
Jun 10, 2022